A new life sciences survey has revealed near-universal agreement across the industry that clinical systems and processes must be streamlined to improve study speed and quality. Here, Rik Van Mol, vice president of R&D strategy, Europe, Veeva Systems, outlines key survey findings and what they mean for the life sciences industry.
Unify and improve
Many of the challenges companies face today in managing clinical trials stem from disparate processes and systems. Nearly all those surveyed (99%) report the need to unify their clinical applications, including CTMS, EDC and eTMF. Respondents cite faster study execution (65%), improved study quality (63%) and cost savings (59%) as the top three most important drivers.